Brian Gennery

Learn More
Orexins have a role in sleep regulation, and orexin receptor antagonists are under development for the treatment of insomnia. We conducted a randomised, double-blind, placebo-controlled, four-period crossover study to investigate the effect of single doses of the dual orexin receptor antagonist SB-649868 (10 or 30 mg) and a positive control zolpidem (10(More)
In a randomised, double-blind placebo-controlled single-centre study we compared the efficacy and safety of 0.75% levobupivacaine (without vasoconstrictor) with 2% lignocaine (with adrenaline 1:80,000) and with placebo for postoperative pain relief in 93 patients having day surgery under general anaesthesia for the removal of impacted mandibular third(More)
A multicentre comparative crossover study of benoxaprofen in the treatment of osteoarthritis was undertaken by general practitioners in the United Kingdom. Rheumatologists from 20 centres helped to coordinate the trial and provided x-ray confirmation of the diagnosis. In predetermined random order, patients were assigned to treatment groups and given either(More)
  • Brian Gennery
  • International Journal of Pharmaceutical Medicine
  • 2012
The launch of Higher Medical Training (HMT) for pharmaceutical physicians took place at the Annual General Meeting of the Faculty on 7 November 2002. At that meeting, the opportunity was taken to restate a number of basic principles that underline HMT. First, it is not about sending people to endless courses and programs. It is about setting, achieving and(More)
  • Brian Gennery
  • International Journal of Pharmaceutical Medicine
  • 2012
The attainment of specialty status for pharmaceutical medicine with its own Certificate of Completion of Specialist Training (CCST), which is expected literally within the next few days, will be a major step in the evolution of the professional standing of those who have chosen to pursue a career in either the pharmaceutical industry or the regulatory(More)
The PHAR-IN ("Competences for industrial pharmacy practice in biotechnology") looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial(More)
  • 1